- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Erich Mounce Emphasizes the Importance of Palliative Care
Erich Mounce, chief operating officer, OneOncology, discusses the importance of palliative care and how it impacts quality of life.
Erich Mounce, chief operating officer, OneOncology, discusses the importance of palliative care and how it impacts quality of life.
Transcript
Palliative care is often underutilized for certain cancers, such as blood cancers. How important is this type of care, and how does it impact patient quality of life?
Hugely important. And the other piece is palliative care doesn’t necessarily mean that you’re going to pass away from cancer. Palliative care is really symptom management, and symptom management especially for high comorbidity patients is difficult. Palliative care physicians, especially if they’re trained and boarded in palliative care, can really provide a good transition for patients that are going through chemotherapy or other treatment modalities that address those symptoms so they don’t end up in the emergency room.
That palliative care entry should be done early on with certain cancers. At West Cancer Center, a founding member of the OneOncology process, they actually brought in a palliative care doctor, 2 of them, in house, that are seeing patients on automatic referrals for certain cancers because we know they’re going to have high symptoms or high changes in the way their lifestyle is while they’re going through cancer therapy. Finally, for patients that do succumb, that palliative care interaction and the introduction into hospice is so much better these days and is so important, if you’re a family member, to go through that end of life process without just sort of being left on a hospital bed to die.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
